
# Enum: WhoAmlEnum




URI: [https://w3id.org/pcdc/model/WhoAmlEnum](https://w3id.org/pcdc/model/WhoAmlEnum)


## Other properties

|  |  |  |
| --- | --- | --- |

## Permissible Values

| Text | Description | Meaning | Other Information |
| :--- | :---: | :---: | ---: |
| AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 | Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1 | ncit:C9288 |  |
| AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | ncit:C9287 |  |
| APL with PML-RARA | Childhood Acute Promyelocytic Leukemia with PML-RARA | ncit:C7968 |  |
| AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3 | Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | ncit:C82403 |  |
| AML with t(6;9)(p23;q34.1);DEK-NUP214 | Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214 | ncit:C82423 |  |
| AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM | Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM | ncit:C82426 |  |
| AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1 | Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.1); RBM15-MKL1 | ncit:C82427 |  |
| Provisional entity: AML with BCR-ABL1 | A rare, de novo acute myeloid leukemia in which the blasts harbor BCR-ABL1 translocation in the absence of a history and clinical and laboratory features of chronic myelogenous leukemia. | ncit:C129785 |  |
| AML with mutated NPM1 | Acute Myeloid Leukemia with Mutated NPM1 | ncit:C82431 |  |
| AML with biallelic mutations of CEBPA | An acute myeloid leukemia with double mutations of the CEBPA gene. | ncit:C129782 |  |
| Provisional entity: AML with mutated RUNX1 | De novo acute myeloid leukemia with RUNX1 gene mutation, not associated with myelodysplastic syndrome-related cytogenetic abnormalities. | ncit:C129786 |  |
| AML with myelodysplasia-related changes | Acute Myeloid Leukemia with Myelodysplasia-Related Changes | ncit:C7600 |  |
| Therapy-related myeloid neoplasms | Acute myeloid leukemias, myelodysplastic syndromes, and myelodysplastic/myeloproliferative neoplasms arising as a result of the mutagenic effect of chemotherapy agents and/or radiation that are used for the treatment of neoplastic or non-neoplastic disorders. | ncit:C27912 |  |
| AML, NOS | Acute Myeloid Leukemia NOS | ncit:C27753 |  |
| AML with minimal differentiation | Acute Myeloid Leukemia with Minimal Differentiation | ncit:C8460 |  |
| AML without maturation | Acute Myeloid Leukemia without Maturation | ncit:C3249 |  |
| AML with maturation | Acute Myeloid Leukemia with Maturation | ncit:C3250 |  |
| Acute myelomonocytic leukemia | Acute Myelomonocytic Leukemia | ncit:C7463 |  |
| Acute monoblastic/monocytic leukemia | Acute Monoblastic and Monocytic Leukemia | ncit:C7318 |  |
| Pure erythroid leukemia | Pure Erythroid Leukemia | ncit:C7467 |  |
| Acute megakaryoblastic leukemia | Acute Megakaryoblastic Leukemia | ncit:C3170 |  |
| Acute basophilic leukemia | Acute Basophilic Leukemia | ncit:C3164 |  |
| Acute panmyelosis with myelofibrosis | Acute Panmyelosis with Myelofibrosis | ncit:C4344 |  |
| Myeloid sarcoma | Myeloid Sarcoma | ncit:C3520 |  |
| Myeloid proliferations related to Down syndrome | Myeloid Proliferations Associated with Down Syndrome | ncit:C82338 |  |
| Transient abnormal myelopoiesis (TAM) | Transient Abnormal Myelopoiesis Associated with Down Syndrome | ncit:C82339 |  |
| Myeloid leukemia associated with Down syndrome | Myeloid Leukemia Associated with Down Syndrome | ncit:C43223 |  |
| Unknown | Reported as unknown by the data contributor. | ncit:C17998 |  |
| Not Reported | Not provided or available. | ncit:C43234 |  |

